CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 10-Q Report Quarterly Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- D Other Notice of Sales of Unregistered Securities
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- SC 13D/A Stake Beneficial Ownership Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,292 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 1,298 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,022 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,160 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 3,731 shares (to pay taxes)
- S-3 Offering Registration Statement
- 10-K Report Annual Report
Page 25 of 41 · 802 filings